150 studies found for:    Open Studies | "Aggression"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting A Brief Intervention to Prevent Adolescent Dating Aggression Perpetration
Conditions: Offensive Aggression;   Sexual Aggression;   Dating Violence Perpetration and Victimization
Intervention: Behavioral: Brief Motivational Interview
2 Unknown  Healthy Brains & Behavior: Understanding and Treating Youth Aggression
Condition: Aggression
Interventions: Behavioral: CBI;   Dietary Supplement: NUT
3 Recruiting Cognitive Behavioral Aggression Treatment
Condition: Aggression
Intervention: Behavioral: Psychotherapy
4 Recruiting CBT for Aggression in Veterans
Conditions: Aggression;   Anger;   Posttraumatic Stress Disorder
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Present Centered Therapy
5 Unknown  Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression
Conditions: Impulsive Aggression;   Posttraumatic Stress Disorder
Interventions: Drug: Phenytoin;   Behavioral: Cognitive Behavioral Therapy
6 Unknown  Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment
Conditions: Adverse Effects;   Aggression
Intervention: Behavioral: comparative computer simulation
7 Unknown  Trial of GemOx±R Regimen in First-line Treatment of Elderly Aggressive B Cell Lymphoma
Condition: Aggressive B Cell Lymphoma
Interventions: Drug: R-GemOx;   Drug: GemOx
8 Recruiting Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
Condition: Relapsed/Refractory Aggressive B-cell Lymphomas
Intervention: Drug: MEDI-551 and MEDI0680 (AMP-514)
9 Recruiting Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma
Condition: CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma
Intervention: Drug: rituximab
10 Recruiting Mechanisms and Treatment Response of Aggressive Periodontitis in Children
Condition: Aggressive Periodontitis
Intervention: Procedure: Periodontal Treatment
11 Recruiting Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis
Conditions: Aggressive Periodontitis;   Chronic Periodontitis
Intervention: Other: flow cytometry
12 Recruiting Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma
Condition: Aggressive Lymphoma
Intervention: Drug: Bendamustine and subcutaneous rituximab
13 Unknown  The Affect of Orthodontic Treatment on the Periodontal Status of Patients With Aggressive Periodontitis
Condition: Aggressive Periodontitis
Intervention: Procedure: orthodontic  treatment
14 Recruiting A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
Condition: Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
Interventions: Drug: lipegfilgrastim;   Drug: pegfilgrastim
15 Recruiting Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Conditions: Adult Acute Lymphoblastic Leukemia;   Adult Acute Myeloid Leukemia;   Adult Diffuse Large B-Cell Lymphoma;   Aggressive Non-Hodgkin Lymphoma;   Childhood Acute Lymphoblastic Leukemia;   Childhood Acute Myeloid Leukemia;   Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Childhood Diffuse Large B -Cell Lymphoma;   DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Myelodysplastic/Myeloproliferative Neoplasm;   Prolymphocytic Leukemia;   Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Stage I Adult Hodgkin Lymphoma;   Stage I Aggressive Adult Non-Hodgkin Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage I Chronic Lymphocytic Leukemia;   Stage I Diffuse Large B-Cell Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage I Small Lymphocytic Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma;   Stage II Contiguous Mantle Cell Lymphoma;   Stage II Diffuse Large B-Cell Lymphoma;   Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma;   Stage II Non-Contiguous Mantle Cell Lymphoma;   Stage II Small Lymphocytic Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Aggressive Adult Non-Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Diffuse Large B-Cell Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Small Lymphocytic Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Aggressive Adult Non-Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Diffuse Large B-Cell Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Small Lymphocytic Lymphoma;   T-Cell Prolymphocytic Leukemia;   Waldenstrom Macroglobulinemia
Interventions: Drug: Atorvastatin Calcium;   Drug: Fludarabine Phosphate;   Radiation: Total-Body Irradiation;   Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclosporine;   Drug: Mycophenolate Mofetil;   Procedure: Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis
16 Recruiting Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents
Conditions: Disruptive Behavior;   Aggression;   Anger;   Irritability;   Noncompliance
Interventions: Behavioral: Cognitive-Behavioral Therapy for Aggression;   Behavioral: Supportive Psychotherapy (SPT)
17 Recruiting Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
Conditions: Adult Acute Lymphoblastic Leukemia;   Adult Acute Myeloid Leukemia;   Adult Nasal Type Extranodal NK/T-Cell Lymphoma;   Aggressive Adult Non-Hodgkin Lymphoma;   Aggressive Non-Hodgkin Lymphoma;   Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative;   Childhood Acute Lymphoblastic Leukemia;   Childhood Acute Myeloid Leukemia;   Childhood Burkitt Lymphoma;   Childhood Diffuse Large B -Cell Lymphoma;   Childhood Immunoblastic Lymphoma;   Childhood Myelodysplastic Syndrome;   Childhood Nasal Type Extranodal NK/T-Cell Lymphoma;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome With Isolated Del(5q);   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Previously Treated Myelodysplastic Syndrome;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-Cell Leukemia/Lymphoma;   Recurrent Aggressive Adult Non-Hodgkin Lymphoma;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Indolent Adult Non-Hodgkin Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides and Sezary Syndrome;   Recurrent Plasma Cell Myeloma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Adult T-Cell Leukemia/Lymphoma;   Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Mantle Cell Lymphoma;   Refractory Plasma Cell Myeloma;   Waldenstrom Macroglobulinemia
Interventions: Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Radiation: Total-Body Irradiation;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus;   Procedure: Allogeneic Bone Marrow Transplantation;   Biological: Natural Killer Cell Therapy;   Other: Laboratory Biomarker Analysis
18 Unknown  Strength at Home Couples Program (PTSD-Focused Relationship Enhancement Therapy for Returning Veterans)
Conditions: Aggression;   Post Traumatic Stress Disorders
Interventions: Behavioral: Strength at Home Couples Group;   Behavioral: Supportive Group Therapy
19 Not yet recruiting Omega-3 Supplementation and Behavior Problems
Conditions: Aggression;   Antisocial Behavior;   Attention Problems;   Anxiety
Interventions: Dietary Supplement: Omega-3 supplemented drink;   Dietary Supplement: Smartfish
20 Recruiting Preventing Violence Among Veterans in Substance Use Disorder Treatment
Conditions: Aggression;   Substance-Related Disorders
Interventions: Behavioral: MI-CBT;   Behavioral: MI-CBT+CC;   Behavioral: E-TAU

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years